Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Selective knockout of the vitamin d receptor in the heart results in cardiac hypertrophy: is the heart a drugable target for vitamin D receptor agonists?

Literature DB >> 22025636

Selective knockout of the vitamin d receptor in the heart results in cardiac hypertrophy: is the heart a drugable target for vitamin D receptor agonists?

Robert U Simpson.

Abstract

Entities: Chemical Disease Gene Species

Mesh：

Substances：
Receptors, Calcitriol

Year: 2011 PMID： 22025636 PMCID： PMC3229031 DOI： 10.1161/CIRCULATIONAHA.111.061234

Source DB: PubMed Journal: Circulation ISSN： 0009-7322 Impact factor: 29.690

× No keyword cloud information.

21 in total

1. Involvement of vitamin D3 with cardiovascular function. II. Direct and indirect effects.

Authors: R E Weishaar; R U Simpson
Journal: Am J Physiol Date: 1987-12

2. Cardiomyocyte-specific deletion of the vitamin D receptor gene results in cardiac hypertrophy.

Authors: Songcang Chen; Christopher S Law; Christopher L Grigsby; Keith Olsen; Ting-Ting Hong; Yan Zhang; Yerem Yeghiazarians; David G Gardner
Journal: Circulation Date: 2011-09-26 Impact factor: 29.690

3. Vitamin D3 and cardiovascular function in rats.

Authors: R E Weishaar; R U Simpson
Journal: J Clin Invest Date: 1987-06 Impact factor: 14.808

Review 4. Fibrosis and hypertensive heart disease.

Authors: K T Weber
Journal: Curr Opin Cardiol Date: 2000-07 Impact factor: 2.161

5. Involvement of vitamin D3 with cardiovascular function. III. Effects on physical and morphological properties.

Authors: R E Weishaar; S N Kim; D E Saunders; R U Simpson
Journal: Am J Physiol Date: 1990-01

6. Immunochemical identification of the 1,25-dihydroxyvitamin D3 receptor protein in human heart.

Authors: T D O'Connell; R U Simpson
Journal: Cell Biol Int Date: 1996-09 Impact factor: 3.612

7. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system.

Authors: Yan Chun Li; Juan Kong; Minjie Wei; Zhou-Feng Chen; Shu Q Liu; Li-Ping Cao
Journal: J Clin Invest Date: 2002-07 Impact factor: 14.808

8. Lower risk for cardiovascular mortality in oral 1alpha-hydroxy vitamin D3 users in a haemodialysis population.

Authors: Tetsuo Shoji; Kayo Shinohara; Eiji Kimoto; Masanori Emoto; Hideki Tahara; Hidenori Koyama; Masaaki Inaba; Shinya Fukumoto; Eiji Ishimura; Takami Miki; Tsutomu Tabata; Yoshiki Nishizawa
Journal: Nephrol Dial Transplant Date: 2004-01 Impact factor: 5.992

9. Identification of 1,25-dihydroxyvitamin D3 receptors and activities in muscle.

Authors: R U Simpson; G A Thomas; A J Arnold
Journal: J Biol Chem Date: 1985-07-25 Impact factor: 5.157

10. Effect of hyperparathyroidism on cardiac function in patients with end-stage renal disease.

Authors: U Gafter; A Battler; M Eldar; D Zevin; H N Neufeld; J Levi
Journal: Nephron Date: 1985 Impact factor: 2.847

8 in total

Review 1. Vitamin D in Cardiovascular Disease.

Authors: Alkippi Nitsa; Marina Toutouza; Nikolaos Machairas; Anargyros Mariolis; Anastassios Philippou; Michael Koutsilieris
Journal: In Vivo Date: 2018 Sep-Oct Impact factor: 2.155

8. Lack of vitamin D signalling per se does not aggravate cardiac functional impairment induced by myocardial infarction in mice.

Authors: Kristopher Ford; Nejla Latic; Svetlana Slavic; Ute Zeitz; Marlies Dolezal; Oleh Andrukhov; Reinhold G Erben; Olena Andrukhova
Journal: PLoS One Date: 2018-10-01 Impact factor: 3.240